Trials / Conditions / Kerato Conjunctivitis Sicca

Kerato Conjunctivitis Sicca

12 registered clinical trials studyying Kerato Conjunctivitis Sicca.

Status	Trial	Sponsor	Phase
Terminated	A Study Evaluating the Safety of the Nasal Pump NCT06329687	Oyster Point Pharma, Inc.	Phase 4
Completed	Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers NCT06176651	Gordon Schanzlin New Vision	Phase 4
Completed	Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye NCT05848128	Mimetogen Pharmaceuticals USA, Inc.	Phase 3
Completed	PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms NCT05825599	C.O.C. Farmaceutici S.r.l.	N/A
Completed	PMCF Study to Evaluate Performance and Safety of "Distilled Waters-based Eyedrops" Used to Relieve Dry Eye Sym NCT05825586	C.O.C. Farmaceutici S.r.l.	N/A
Completed	PMCF Study to Evaluate Performance and Safety of "Hyaluronic Acid (HA)-Based Eyedrops" Used to Relieve Dry Eye NCT05807360	C.O.C. Farmaceutici S.r.l.	N/A
Completed	PMCF Study to Evaluate Performance and Safety of "CLHA-based Eyedrops" Used to Improve Lacrimal Abnormalities NCT05823961	C.O.C. Farmaceutici S.r.l.	N/A
Completed	PMCF Study to Evaluate Performance and Safety of "Ocular Drops Based Upon Carmellose" Used to Relieve Dry Eye NCT05825352	C.O.C. Farmaceutici S.r.l.	N/A
Completed	Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease NCT05119920	Glaukos Corporation	Phase 2
Completed	Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Di NCT03878628	Rigshospitalet, Denmark	EARLY_Phase 1
Unknown	DRy Eye Outcome and Prescription Study NCT03652415	Guy's and St Thomas' NHS Foundation Trust	—
Completed	Safety and Efficacy of KPI-121 in Subjects With DED NCT03616899	Kala Pharmaceuticals, Inc.	Phase 3